Senior Director, Bioanalytical Sciences (CMC Operations)
Area of Expertise: Ideation & Innovation
In 2018, John Rolf, Ph.D. became Senior Director of Bioanalytical Sciences (CMC Operations) at Xencor where he leads the analytical team responsible for advancing pipeline molecules into clinical studies. Xencor is a clinical-stage biotechnology company developing engineered therapeutic monoclonal antibodies.
From 2006 to 2018, John worked at Amgen as a Director of Product Quality and a Product Quality Leader for Amgen’s commercial program. Prior to Amgen, he worked in product and process development at several other biotechnology companies.
John has a Ph.D. in Immunology from the University of Texas Southwestern Medical Center at Dallas.